Concepedia

Jonathan Kearsey

JK

5

Publications

312

Citations

5

H-Index

2004

Active since

Affiliations

Institut Claudius Regaud(Current)

Jonathan Kearsey is an author at Institut Claudius Regaud specializing in extracellular matrix, medicine, and cytoskeleton.

Top concepts

Publications per year

2004–2008

5

Publications

5

Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules

Catherine de Coupade, Antonio Fittipaldi, Vanessa Chagnas et al. · Biochemical Journal · 2005 · 134 citations · Full text

, , +22

DTS-108, A Novel Peptidic Prodrug of SN38: <i>In vivo</i> Efficacy and Toxicokinetic Studies

Florence Meyer-Losic, Céline Nicolazzi, Jérôme Quinonero et al. · Clinical Cancer Research · 2008 · 70 citations · Full text

Improved Therapeutic Efficacy of Doxorubicin through Conjugation with a Novel Peptide Drug Delivery Technology (Vectocell)

Florence Meyer-Losic, Jérôme Quinonero, Vincent Dubois et al. · Journal of Medicinal Chemistry · 2006 · 53 citations

Preclinical Toxicity, Toxicokinetics, and Antitumoral Efficacy Studies of DTS-201, a Tumor-Selective Peptidic Prodrug of Doxorubicin

Denis Ravel, Vincent Dubois, Jérôme Quinonero et al. · Clinical Cancer Research · 2008 · 30 citations · Full text

A novel four transmembrane spanning protein, CLP24

Jonathan Kearsey, Silvere Petit, Catherine De Oliveira et al. · European Journal of Biochemistry · 2004 · 25 citations · Full text

, , +18

Rows per page

1–5 of 5